{
    "title": "Machine Learning Small Molecule Properties in Drug Discovery. (arXiv:2308.12354v1 [q-bio.BM])",
    "abstract": "Machine learning (ML) is a promising approach for predicting small molecule properties in drug discovery. Here, we provide a comprehensive overview of various ML methods introduced for this purpose in recent years. We review a wide range of properties, including binding affinities, solubility, and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). We discuss existing popular datasets and molecular descriptors and embeddings, such as chemical fingerprints and graph-based neural networks. We highlight also challenges of predicting and optimizing multiple properties during hit-to-lead and lead optimization stages of drug discovery and explore briefly possible multi-objective optimization techniques that can be used to balance diverse properties while optimizing lead candidates. Finally, techniques to provide an understanding of model predictions, especially for critical decision-making in drug discovery are assessed. Overall, this review provides insights into the land",
    "link": "http://arxiv.org/abs/2308.12354",
    "context": "Title: Machine Learning Small Molecule Properties in Drug Discovery. (arXiv:2308.12354v1 [q-bio.BM])\nAbstract: Machine learning (ML) is a promising approach for predicting small molecule properties in drug discovery. Here, we provide a comprehensive overview of various ML methods introduced for this purpose in recent years. We review a wide range of properties, including binding affinities, solubility, and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). We discuss existing popular datasets and molecular descriptors and embeddings, such as chemical fingerprints and graph-based neural networks. We highlight also challenges of predicting and optimizing multiple properties during hit-to-lead and lead optimization stages of drug discovery and explore briefly possible multi-objective optimization techniques that can be used to balance diverse properties while optimizing lead candidates. Finally, techniques to provide an understanding of model predictions, especially for critical decision-making in drug discovery are assessed. Overall, this review provides insights into the land",
    "path": "papers/23/08/2308.12354.json",
    "total_tokens": 905,
    "translated_title": "机器学习在药物发现中预测小分子性质的研究",
    "translated_abstract": "机器学习（ML）是一种在药物发现中预测小分子性质的有前景的方法。本文综述了近年来为此目的引入的各种ML方法。我们审查了一系列性质，包括结合亲和力、溶解度和ADMET（吸收、分布、代谢、排泄和毒性）。我们讨论了现有的流行数据集和分子描述符和嵌入方法，如化学指纹和基于图的神经网络。我们还强调了在药物发现的命中优选和优化引导阶段预测和优化多个性质的挑战，并简要探讨了可能用于平衡不同性质的多目标优化技术。最后，我们评估了提供模型预测理解的技术，特别是在药物发现中关键决策的情况下。总的来说，本综述提供了对机器学习在药物发现中预测小分子性质方面的洞察。",
    "tldr": "这篇综述介绍了机器学习在药物发现中预测小分子性质的方法，并讨论了不同性质的预测和优化挑战以及多目标优化技术的应用。同时评估了提供模型预测理解的技术对药物发现中的决策的重要性。",
    "en_tdlr": "This review provides insights into the application of machine learning in predicting small molecule properties in drug discovery, discussing challenges in predicting and optimizing diverse properties and evaluating techniques to provide model prediction understanding for critical decision-making."
}